[B! å…ç–«] belgianbeerã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯

belgianbeer id:belgianbeer

å…ç–«ã«é–¢ã™ã‚‹belgianbeerã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯ (8)

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

${{author_name}}$
{{author_name}}{{created}}
{{ #comment }}{{ comment }}{{ /comment }}
- {{ label }}

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

[ç¿»è¨³] BioNTech/Pfizer ã®æ–°åž‹ã‚³ãƒãƒŠãƒ¯ã‚¯ãƒãƒ³ã‚’ã€ˆãƒªãƒãƒ¼ã‚¹ã‚¨ãƒ³ã‚¸ãƒ‹ã‚¢ãƒªãƒ³ã‚°ã€‰ã™ã‚‹ï½œæŸžåˆˆæ¹¯è‘‰
æœ¬è¨˜äº‹ã¯Â Bert Hubert ã«ã‚ˆã‚‹ [Reverse Engineering the source code of the BioNTech/Pfizer SARS-CoV-2 Vaccine]Â ã‚’è¨±å¯ã‚’å¾—ã¦æ—¥æœ¬èªžè¨³ã—ãŸã‚‚ã®ã§ã™ã€‚ ã¯ã˜ã‚ã«ã‚ˆã†ã“ãã€‚ã“ã®è¨˜äº‹ã§ã¯ã€ãƒã‚¤ã‚ªãƒ³ãƒ†ãƒƒã‚¯ç¤¾ãƒ»ãƒ•ã‚¡ã‚¤ã‚¶ãƒ¼ç¤¾ã«ã‚ˆã‚‹æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã® mRNA ãƒ¯ã‚¯ãƒãƒ³ã®ã‚½ãƒ¼ã‚¹ã‚³ãƒ¼ãƒ‰ã‚’ã€1æ–‡å—ãšã¤è§£èªã—ã¦ã„ãã¾ã™ã€‚ æœ¬è¨˜äº‹ã‚’èªã¿ã‚„ã™ãã€æ£ã—ã„ã‚‚ã®ã¨ã™ã‚‹ãŸã‚ã«æ™‚é–“ã‚’å‰²ã„ã¦ã„ãŸã ã„ãŸå¤šãã®æ–¹ã€…ã«æ„Ÿè¬ã„ãŸã—ã¾ã™ã€‚é–“é•ã„ã¯ã™ã¹ã¦ç§ã®è²¬ä»»ã«å±žã—ã¾ã™ãŒã€ bert@hubertnet.nl ã¾ãŸã¯Â @PowerDNS_BertÂ ã¾ã§ãŠçŸ¥ã‚‰ã›ã„ãŸã ã‘ã‚‹ã¨å¹¸ã„ã§ã™ã€‚ã€”è¨³æ³¨ï¼šç¿»è¨³ã«é–¢ã™ã‚‹æŒ‡æ‘˜ã¯æŸžåˆˆæ¹¯è‘‰ @yubais ã¾ã§ã€‚ã€• ã€Œãƒ¯ã‚¯ãƒãƒ³ã®ã‚½ãƒ¼ã‚¹ã‚³ãƒ¼ãƒ‰ã€ã ã£ã¦ï¼Ÿã€€ãƒ¯ã‚¯ãƒãƒ³ã¯è…•ã«æ³¨å°„ã™ã‚‹æ¶²ä½“ã ã‚ã€ãã®ã‚½ãƒ¼ã‚¹ã‚³ãƒ¼ãƒ‰ã£ã¦ä½•ã ã‚ˆï¼Ÿã€€ã¨æ€ã‚ã‚Œ
belgianbeer 2021/07/07
Bert Hubertã£ã¦ã“ã‚“ãªã“ã¨ã‚‚ã‚„ã£ã¦ãŸã®ã‹ã€‚ãƒ“ãƒƒã‚¯ãƒªã—ãŸã‚

å…ç–«

ã‚¦ã‚£ãƒ«ã‚¹

COVID-19
ãƒªãƒ³ã‚¯
äº¬å¤§ç ”ç©¶è€…ãŒæ˜Žè¨€ã€Œå†è‡ªç²›ä¸è¦è«–ã€ã€€æ¬§ç±³ã‚ˆã‚Šåœ§å€’çš„ã«ä½Žã„æ—¥æœ¬ã®æ»äº¡çŽ‡â€¦ã“ã®å·®ã¯ã€Œé›†å›£å…ç–«ã€ã§èª¬æ˜Žã§ãã‚‹ã€€æŠ—ä½“æ¤œæŸ»ã«ã¯ç›²ç‚¹ã‚‚ï¼ˆ1/4ãƒšãƒ¼ã‚¸ï¼‰
æ—¥æœ¬ã®æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ã«ã‚ˆã‚‹æ»è€…æ•°ã‚„æ»äº¡çŽ‡ãŒæ¬§ç±³ã‚ˆã‚Šåœ§å€’çš„ã«å°‘ãªã„ç†ç”±ã«ã¤ã„ã¦ã€å¤•åˆŠãƒ•ã‚¸ã§ã¯ï¼•æœˆã«ã€Œæ—¥æœ¬äººã¯ã™ã§ã«é›†å›£å…ç–«ã‚’ç²å¾—ã—ã¦ã„ã‚‹ã€ã¨ã„ã†ç ”ç©¶ã‚°ãƒ«ãƒ¼ãƒ—ã®ä»®èª¬ã‚’å ±ã˜ãŸã€‚ãã®å¾Œã€å›½å†…ã®æŠ—ä½“ä¿æœ‰çŽ‡ãŒä½Žã„ã¨ã„ã†èª¿æŸ»çµæžœã‚„ã€æŠ—ä½“ãŒçŸæœŸé–“ã§æ¶ˆãˆã‚‹ã¨ã™ã‚‹æµ·å¤–ã®å ±å‘Šã‚‚å‡ºã¦ããŸãŒã€ç ”ç©¶ã‚°ãƒ«ãƒ¼ãƒ—ã¯ã€Œé›†å›£å…ç–«ç†è«–ã‚’è¦†ã™ã‚‚ã®ã§ã¯ãªã„ã€ã¨å¼·èª¿ã™ã‚‹ã€‚æ±äº¬éƒ½ã‚’ä¸å¿ƒã«å…¨å›½ã§æ„ŸæŸ“è€…ãŒå†ã³å¢—ãˆã¦ã„ã‚‹ãŒã€ã€Œè‡ªç²›ã¯ä¸è¦ã€ã¨ã‚‚æ˜Žè¨€ã—ãŸã€‚ äº¬éƒ½å¤§å¦å¤§å¦é™¢åŒ»å¦ç ”ç©¶ç§‘ã®ä¸Šä¹…ä¿é–å½¦ç‰¹å®šæ•™æŽˆã¨é †å¤©å ‚å¤§ã®å¥¥æ‘åº·ï¼ˆã“ã†ï¼‰ç‰¹ä»»æ•™æŽˆï¼ˆå…ç–«å¦ï¼‰ã¯ï¼’ï¼—æ—¥ã€è¨˜è€…ä¼šè¦‹ã‚’é–‹ãã€ã“ã®ã¨ã“ã‚æ„ŸæŸ“è€…æ•°ãŒå¢—åŠ ã—ã¦ã„ã‚‹ãŒã€ã€Œï¼“é€±é–“çµŒéŽã—ã¦ã‚‚æ»è€…æ•°ã¯æ¨ªã°ã„ã ã€ã¨ã—ã€æ„ŸæŸ“è€…ã®å¢—åŠ ã¯ï¼°ï¼£ï¼²æ¤œæŸ»æ•°ã®å¢—å¤§ã¨ç›¸é–¢ã—ã¦ã„ã‚‹ã¨ã®è¦‹è§£ã‚’ç¤ºã—ãŸã€‚ ç±³ã‚¸ãƒ§ãƒ³ã‚ºãƒ»ãƒ›ãƒ—ã‚ãƒ³ã‚ºå¤§ã®é›†è¨ˆã«ã‚ˆã‚‹ã¨ã€ï¼’ï¼—æ—¥ç¾åœ¨ã®æ—¥æœ¬å›½å†…ã®æ»è€…ã¯ï¼™ï¼™ï¼˜äººï¼ˆäººå£ï¼‘ï¼ï¼ä¸‡äººã‚ãŸã‚Šï¼—ãƒ»ï¼™äººï¼‰ã€‚ç±³å›½ã®ï¼‘ï¼”ä¸‡ï¼–ï¼™ï¼“ï¼•
belgianbeer 2020/07/29
æžœãŸã—ã¦ã©ã†ãªã‚“ã ã‚ã†ã‹

å…ç–«

COVID-19
ãƒªãƒ³ã‚¯
æ¬§ç±³ã®ã‚³ãƒãƒŠã¯å®Œå…¨ã«çµ‚æ¯ãƒ¢ãƒ¼ãƒ‰ã€‚ã‚‚ã¡ã‚ã‚“æ—¥æœ¬ã‚‚ãã€‚ï½œMore Access! More Fun
ã‚ãŸã—ãŒä¸»å‚¬ã—ã¦ã„ã¾ã™ã€Œ21ä¸–ç´€ã‚’ç”Ÿãæ®‹ã‚‹ãŸã‚ã®ã€Œæ°¸æ±Ÿã€€è™Žã®ç©´å¡¾ã€ã§ã¯ï¼—æœˆåº¦ã®å¡¾ç”Ÿã‚’å‹Ÿé›†ã—ã¦ã„ã¾ã™ã€‚ã‚³ãƒãƒŠç¦ã®é–“ã€å¸Œæœ›è€…ã¯æ¯Žæœˆ30åˆ†ã€‚ã‚ãŸã—ã¨1:1ã§zoomã§ãƒ–ãƒ¬ã‚¹ãƒˆãŒã§ãã¾ã™ã€‚ã²ã¨ã‚Šãšã¤ä¸å¯§ã«ã‚„ã£ã¦ã¾ã™ã‚ˆã€‚ â€»å¤§ããªä»•äº‹ãŒãµãŸã¤çµ‚ã‚ã‚Šã¾ã™ã®ã§æ‰‹ãŒç©ºãã¾ã—ãŸã€‚äº‹æ¥ãƒ»é›†å®¢ã‚³ãƒ³ã‚µãƒ«ã‚„ã‚µã‚¤ãƒˆæ§‹ç¯‰ã®ã”ä¾é ¼ã‚‚çµ¶è³›å—ã‘ä»˜ã‘ã¦ãŠã‚Šã¾ã™ã€‚ æ—¥æœ¬ã§ã¯æ±äº¬ã§1æ—¥100äººã®æ„ŸæŸ“è€…ãŒç™ºè¦‹ã•ã‚Œã¦ã„ã¾ã™ãŒã€å®Ÿã«å¥‡å¦™ãªç¾è±¡ãŒèµ·ãã¦ã„ã¾ã™ã€‚ æ±äº¬ã®é‡ç—‡è€…ã®æŽ¨ç§»ã¯ã“ã‚Œ é‡ç—‡è€…ãŒæ¿€æ¸›ã—ã¦ãŸã£ãŸã®9äºº!!! ãƒ”ãƒ¼ã‚¯æ™‚ã«ã¯100äººã‚’ã‹ãªã‚Šè¶…ãˆã¦ã„ãŸã®ã«ã„ã¾ã‚„ãŸã£ãŸã®9äººã§ã™ã€‚è‹¥è€…ä¸å¿ƒã«æ„ŸæŸ“ãŒåºƒãŒã£ã¦ã„ã‚‹ã®ãŒæ±äº¬ã§ã™ãŒã€å®Ÿã¯å…¨å›½ã§ã‚‚ é‡ç—‡è€…ã¯ãƒ”ãƒ¼ã‚¯æ™‚ã®1/10ã§æ¸›å°‘ä¸ ã‚³ãƒãƒŠè„³ã®çš†ã•ã‚“ã®ä¸ã«ã¯ä»¥å‰ã‚ã‚Œã»ã©ã€Œã‚³ãƒãƒŠãŒæã‚ã—ã„ã®ã¯ç½¹æ‚£ã—ã¦ã™ãã«é‡ç—‡åŒ–ã™ã‚‹ã“ã¨ã ã€ã¨å«ã‚“ã§ã„ãŸã®ã«ã„ã¾ã‚„ã€Œæ™‚å·®ãŒã‚ã‚‹ã‹ã‚‰æ•°é€±é–“å¾Œã«é‡ç—‡åŒ–ã™ã‚‹ã€ã¨ã‹é¨’ã„ã§ã„
belgianbeer 2020/07/07
ä¸æ€è°ãªã‚“ã ã‚ˆãªãã€‚ã©ã†ã—ã¦ã“ã†è½ã¡ç€ã„ã¦ãã¦ã„ã‚‹ã®ã‹ã€‚

COVID-19

å…ç–«
ãƒªãƒ³ã‚¯
æ–°åž‹ã‚³ãƒãƒŠã®ãƒ¯ã‚¯ãƒãƒ³é–‹ç™ºã«è¿½ã„é¢¨ã¨ãªã‚‹çŸ¥è¦‹ãŒæ˜Žã‚‰ã‹ã«
æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ï¼ˆSARS-CoV-2ï¼‰ã«å¯¾ã™ã‚‹ãƒ¯ã‚¯ãƒãƒ³ãŒã€ä¸–ç•Œä¸ã‹ã‚‰ç†±æœ›ã•ã‚Œã¦ã„ã‚‹ã€‚2020å¹´5æœˆ22æ—¥ã«ä¸–ç•Œä¿å¥æ©Ÿé–¢ï¼ˆWHOï¼‰ãŒç™ºè¡¨ã—ãŸã€ŒDraft landscape of COVID-19 candidate vaccinesã€ã«ã‚ˆã‚Œã°ã€ä¸–ç•Œã§ã¯ã€100å“ç›®ä»¥ä¸Šã®ãƒ¯ã‚¯ãƒãƒ³ã®é–‹ç™ºãŒé€²ã‚ã‚‰ã‚Œã¦ãŠã‚Šã€10å“ç›®ã§è‡¨åºŠè©¦é¨“ãŒå®Ÿæ–½ã•ã‚Œã¦ã„ã‚‹ã€‚ãã‚“ãªä¸ã€ãƒ¯ã‚¯ãƒãƒ³é–‹ç™ºã«è¿½ã„é¢¨ã¨ãªã‚‹çŸ¥è¦‹ãŒç™ºè¡¨ã•ã‚ŒãŸã€‚ æœ‰åŠ¹ãªãƒ¯ã‚¯ãƒãƒ³ã‚’é–‹ç™ºã™ã‚‹ãŸã‚ã«ã¯ã€æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ï¼ˆCOVID-19ï¼‰ã®ç—…å› ã«ã¤ã„ã¦ã®æƒ…å ±ã ã‘ã§ãªãã€æ„ŸæŸ“ã—ãŸæ‚£è€…ã®SARS-CoV-2ã«å¯¾ã™ã‚‹å…ç–«å¿œç”ã«é–¢ã™ã‚‹æƒ…å ±ãŒå¿…è¦ã§ã‚ã‚‹ãŒã€ãã†ã—ãŸå ±å‘Šã¯ã“ã‚Œã¾ã§ã»ã¨ã‚“ã©ç„¡ã‹ã£ãŸã€‚ç‰¹ã«ã€ï¼ˆ1ï¼‰æ„ŸæŸ“ã—ãŸæ‚£è€…ã®å…ç–«ç³»ã«ã‚ˆã£ã¦SARS-CoV-2ã«å¯¾ã—ã¦ã©ã®ã‚ˆã†ãªå…ç–«å¿œç”ãŒèª˜å°Žã•ã‚Œã¦ã„ã‚‹ã®ã‹ã€ï¼ˆ2ï¼‰ãã®å…ç–«å¿œç”ã¯æŒç¶šã™ã‚‹ã®ã‹ã€ï¼ˆ3ï¼‰è‡ªç„¶ç•Œã«å˜åœ¨ã™ã‚‹ã€ã„ã‚ã‚†ã‚‹
belgianbeer 2020/05/28
è‰¯ã„çµæžœãŒå¾—ã‚‰ã‚Œã¦ã„ã‚‹ã‚ˆã†ã ã€‚èˆˆå‘³æ·±ã„

å…ç–«

COVID-19
ãƒªãƒ³ã‚¯
ä¸€èˆ¬ã«ä¿¡ã˜ã‚‰ã‚Œã¦ã„ã‚‹é›†å›£å…ç–«ç†è«–ã¯ã©ã“ãŒãŠã‹ã—ã„ã®ã‹å…ç–«ã®å®®å‚å…ˆç”Ÿã«å°‹ãã¦ã¿ã¾ã—ãŸï¼ˆä¸Šï¼‰ï¼ˆæœ¨æ‘æ£äººï¼‰ - ã‚¨ã‚ã‚¹ãƒ‘ãƒ¼ãƒˆ - Yahoo!ãƒ‹ãƒ¥ãƒ¼ã‚¹
ï¼»ãƒãƒ³ãƒ‰ãƒ³ç™ºï¼½æ„ŸæŸ“ç—‡æ•°ç†ãƒ¢ãƒ‡ãƒ«ã¯é›†å›£å…ç–«ç†è«–ã«åŸºã¥ã„ã¦ã„ã¾ã™ã€‚ã—ã‹ã—æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã«æ„ŸæŸ“ã—ã¦æŠ—ä½“ã‚’æŒã¤äººãŒä¸€å®šç¨‹åº¦ã€å¢—ãˆã‚Œã°ã€ãã†ã—ãŸäººãŸã¡ãŒå£ã«ãªã£ã¦æµè¡Œã¯æœ¬å½“ã«çµ‚æ¯ã«å‘ã‹ã†ã®ã§ã—ã‚‡ã†ã‹ã€‚ ãƒ†ãƒ¬ãƒ“ã§ã‚‚ã™ã£ã‹ã‚ŠãŠé¦´æŸ“ã¿ã«ãªã£ãŸå…ç–«å¦ã®ç¬¬ä¸€äººè€…ã§ã‚ã‚‹å¤§é˜ªå¤§å¦å…ç–«å¦ãƒ•ãƒãƒ³ãƒ†ã‚£ã‚¢ç ”ç©¶ã‚»ãƒ³ã‚¿ãƒ¼ã®å®®å‚æ˜Œä¹‹æ‹›ã¸ã„æ•™æŽˆã«ãƒ†ãƒ¬ãƒ“é›»è©±ã‚’é€šã˜ã¦è³ªå•ã—ã¦ã¿ã¾ã—ãŸã€‚ æœ¨æ‘ï¼šåŠ è—¤å‹ä¿¡åŽšç”ŸåŠ´åƒç›¸ãŒ15æ—¥ã€çŒ®è¡€ã•ã‚ŒãŸè¡€æ¶²ã§æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®æŠ—ä½“ã‚’èª¿ã¹ãŸã¨ã“ã‚é™½æ€§çŽ‡ã¯æ±äº¬éƒ½ã®500æ¤œä½“ã§0.6%ã€æ±åŒ—ï¼–çœŒã®500æ¤œä½“ã§ã¯0.4%ã ã£ãŸã¨æ˜Žã‚‰ã‹ã«ã—ã¾ã—ãŸã€‚ å¤§è¦æ¨¡æŠ—ä½“èª¿æŸ»ã‚’æ¥æœˆã‹ã‚‰å®Ÿæ–½ã™ã‚‹ãã†ã§ã™ãŒã€ã©ã‚“ãªæ„å‘³ã‚’æŒã¤ã®ã§ã—ã‚‡ã†ã€‚ å®®å‚æ°ï¼šä½¿ã‚ã‚ŒãŸã‚ãƒƒãƒˆãŒã©ã“ã®ã‚‚ã®ã‹å…¬è¡¨ã•ã‚Œã¦ã„ã¾ã›ã‚“ã€‚æŠ—ä½“æ¤œæŸ»ã‚ãƒƒãƒˆã®ä¸ã«ã¯ç²¾åº¦ã‚‚æ„Ÿåº¦ã‚‚æ‚ªã„ã‚‚ã®ãŒã‚ã‚Šã¾ã™ã€‚ä»Šå›žã®é™½æ€§çŽ‡ã¯ã‹ãªã‚Šä½Žãå‡ºã¦ãŠã‚Šã€è§£é‡ˆãŒé›£ã—ã„ã¨æ€ã„ã¾ã™ã€‚ æœ€è¿‘å‡ºãŸè«–æ–‡ã§ã¯14
belgianbeer 2020/05/19
ä»Šå›žã®ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®å ´åˆã¯2å‰²ç¨‹åº¦ã§é›†å›£å…ç–«ãŒç¢ºä¿ã§ãã‚‹ã‚‰ã—ã„

å…ç–«

COVID-19

ç ”ç©¶

æŠ—ä½“

åŒ»ç™‚
ãƒªãƒ³ã‚¯
æ–°åž‹ã‚³ãƒãƒŠã€æ—¥æœ¬äººã®ä½Žæ»äº¡çŽ‡ã«æ–°ä»®èª¬â€¦ã™ã§ã«é›†å›£å…ç–«ãŒç¢ºç«‹ã•ã‚Œã¦ã„ã‚‹ï¼ï¼Ÿã€€è˜è€…ã€Œå…¥å›½åˆ¶é™ã®é…ã‚ŒãŒçµæžœçš„ã«å¥åŠŸã‹ã€
æ—¥æœ¬ã®æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹å¯¾ç–ã¯ã€Œï¼°ï¼£ï¼²æ¤œæŸ»ãŒå°‘ãªã„ã€ã€Œè‡ªç²›æŽªç½®ãŒç”˜ã„ã€ãªã©ã®æ‰¹åˆ¤ã‚‚ã‚ã‚Šã€åŽšåŠ´çœã¯ï¼˜æ—¥ã€æ„ŸæŸ“ã®æœ‰ç„¡ã‚’èª¿ã¹ã‚‹ï¼°ï¼£ï¼²æ¤œæŸ»ã‚„æ²»ç™‚ã«å‘ã‘ãŸç›¸è«‡ãƒ»å—è¨ºã®ç›®å®‰ã‚’è¦‹ç›´ã—ã€å…¬è¡¨ã—ãŸã€‚ãŸã ã€æ¬§ç±³è«¸å›½ã«æ¯”ã¹ã¦ã€æ—¥æœ¬ã®æ»è€…æ•°ã‚„æ»äº¡çŽ‡ãŒã‚±ã‚¿é•ã„ã«å°‘ãªã„ã®ã¯åŽ³ç„¶ãŸã‚‹äº‹å®Ÿã§ã‚ã‚‹ã€‚ã“ã®è¬Žã«ã¤ã„ã¦ã€äº¬éƒ½å¤§å¦å¤§å¦é™¢åŒ»å¦ç ”ç©¶ç§‘ã®ä¸Šä¹…ä¿é–å½¦ç‰¹å®šæ•™æŽˆã¨ã€å‰å‚™å›½éš›å¤§å¦ï¼ˆå²¡å±±çœŒï¼‰ã®é«˜æ©‹æ·³æ•™æŽˆã‚‰ã®ç ”ç©¶ã‚°ãƒ«ãƒ¼ãƒ—ãŒã€Œæ—¥æœ¬ã§ã¯ã™ã§ã«æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã«å¯¾ã™ã‚‹é›†å›£å…ç–«ãŒç¢ºç«‹ã•ã‚Œã¦ã„ã‚‹ã€ã¨ã„ã†ä»®èª¬ã‚’ç™ºè¡¨ã—ã¦æ³¨ç›®ã•ã‚Œã¦ã„ã‚‹ã€‚æ„ŸæŸ“åŠ›ã‚„æ¯’æ€§ã®ç•°ãªã‚‹ï¼“ã¤ã®åž‹ã®ã‚¦ã‚¤ãƒ«ã‚¹ï¼ˆï¼³åž‹ã¨ï¼«åž‹ã€ï¼§åž‹ï¼‰ã®æ‹¡æ•£æ™‚æœŸãŒé‡ç—‡åŒ–ã«å½±éŸ¿ã—ãŸã¨ã„ã„ã€æ—¥æœ¬ã¯å…¥å›½åˆ¶é™ãŒé…ã‚ŒãŸã“ã¨ãŒçµæžœçš„ã«å¥åŠŸã—ãŸã¨ã„ã†ã®ã ã€‚
belgianbeer 2020/05/10
å®Ÿéš›ã®ã¨ã“ã‚ã¯ã¯ã£ãã‚Šã—ãªã„ãŒã€ç¢ºã‹ã«ã‚ã‚‹ã®ã‹ã‚‚

COVID-19

æ—¥æœ¬

å…ç–«
ãƒªãƒ³ã‚¯
WHAT'S CORONA | Jikei COVID-19 PCR
æ±äº¬æ…ˆæµä¼šåŒ»ç§‘å¤§å¦ ã‚¦ã‚¤ãƒ«ã‚¹å¦è¬›åº§ æ•™æŽˆ è¿‘è—¤ä¸€åš ã€ã¯ã˜ã‚ã«ã€‘ ãƒ’ãƒˆã«æ„ŸæŸ“ã™ã‚‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã«ã¯ã€é¢¨é‚ªã‚’èµ·ã“ã™4ç¨®é¡žã®ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã€é‡ç—‡æ€¥æ€§å‘¼å¸å™¨ç—‡å€™ç¾¤ã‚’èµ·ã“ã™SARSã‚¦ã‚¤ãƒ«ã‚¹ã€ä¸æ±å‘¼å¸å™¨ç—‡å€™ç¾¤ã‚’èµ·ã“ã™MERSã‚¦ã‚¤ãƒ«ã‚¹ã€ãã—ã¦ä»Šå›žå•é¡Œã¨ãªã£ã¦ã„ã‚‹æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ãŒã‚ã‚Šã¾ã™ã€‚æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã«é–¢ã™ã‚‹ã‚¦ã‚¤ãƒ«ã‚¹å¦çš„ãªæƒ…å ±ã¯æœªã ä¹ã—ã„ã§ã™ãŒã€SARSã‚¦ã‚¤ãƒ«ã‚¹ã¨è‰¯ãä¼¼ãŸæ€§è³ªã‚’æŒã£ã¦ã„ã‚‹ã¨è€ƒãˆã‚‰ã‚Œã¦ã„ã¾ã™ã€‚ã“ã“ã§ã¯ã€SARSã‚¦ã‚¤ãƒ«ã‚¹ã‚„æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®ç ”ç©¶ã‹ã‚‰å¾—ã‚‰ã‚ŒãŸæ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®æ€§è³ªã‚’ç´¹ä»‹ã—ã€è¨ºæ–ã€äºˆé˜²ã€æ²»ç™‚ã«ã©ã®ã‚ˆã†ã«ã¤ãªãŒã£ã¦ã„ã‚‹ã®ã‹ã‚’è§£èª¬ã—ã¦ã„ããŸã„ã¨æ€ã„ã¾ã™ã€‚ â€‹ â€‹ â€‹ â€‹ â€‹ â€‹ â€‹ â€‹ â€‹ â€‹ ã€æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®æ§‹é€ ã¨æ¶ˆæ¯’æ³•ã€‘ ã‚¦ã‚¤ãƒ«ã‚¹ã®æ§‹é€ ã¯æ¶ˆæ¯’æ³•ã¨å¯†æŽ¥ãªé–¢ä¿‚ãŒã‚ã‚Šã¾ã™ã€‚ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã¯æ•™ç§‘æ›¸çš„ã«ã¯ã‚¨ãƒ³ãƒ™ãƒãƒ¼ãƒ—ã‚’æŒã¤ã‚¦ã‚¤ãƒ«ã‚¹(ã‚¨ãƒ³ãƒ™ãƒãƒ¼ãƒ—ã‚¦ã‚¤ãƒ«ã‚¹)ã«åˆ†é¡žã•ã‚Œã¾ã™ã€‚
belgianbeer 2020/05/06
å†åº¦æ„ŸæŸ“ã™ã‚‹ã‹ã©ã†ã‹ã«ã¤ã„ã¦ã®è¦‹è˜ãŒQAã®æœ€å¾Œã«ã‚ã‚‹

COVID-19

å…ç–«

åŒ»ç™‚
ãƒªãƒ³ã‚¯
ã‚¹ã‚¦ã‚§ãƒ¼ãƒ‡ãƒ³ã€ãƒãƒƒã‚¯ãƒ€ã‚¦ãƒ³ã›ãšæ–°åž‹ã‚³ãƒãƒŠå¯¾ç–æˆåŠŸã‹ã€€ç–«å¦è€…ãŒä¸»å¼µã€Œ5æœˆä¸ã«ã‚‚é›†å›£å…ç–«ç²å¾—ã€
ä¸–ç•Œä¸ã§çŒ›å¨ã‚’ãµã‚‹ã†æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã€‚å„å›½ã§æ§˜ã€…ãªæ‹¡å¤§é˜²æ¢ç–ãŒå–ã‚‰ã‚Œã‚‹ä¸ã€ã‚¹ã‚¦ã‚§ãƒ¼ãƒ‡ãƒ³ã§ã¯å¦æ ¡ã€ã‚¸ãƒ ã€ãƒ¬ã‚¹ãƒˆãƒ©ãƒ³ãªã©ãŒå–¶æ¥ã‚’ç¶šã‘ãªãŒã‚‰ã‚‚å›½æ°‘ã¸ã€Œã‚½ãƒ¼ã‚·ãƒ£ãƒ«ãƒ»ãƒ‡ã‚£ã‚¹ã‚¿ãƒ³ã‚¹ã€ã‚’æ„è˜ã™ã‚‹ã‚ˆã†ã«å‘¼ã³ã‹ã‘ã€å¯¾å¿œã—ã¦ããŸã€‚ãã‚“ãªä¸ã§ã‚¹ã‚¦ã‚§ãƒ¼ãƒ‡ãƒ³å…¬è¡†è¡›ç”Ÿå±€ã®ç–«å¦è€…ã‚¢ãƒ³ãƒ€ãƒ¼ã‚¹ãƒ»ãƒ†ã‚°ãƒãƒ«æ°ãŒã€Œé›†å›£å…ç–«ã‚’æŒã¡å§‹ã‚ãŸã€ã¨ã®è€ƒãˆã‚’ç¤ºã—ãŸã“ã¨ã‚’19æ—¥(æ—¥æœ¬æ™‚é–“20æ—¥)ã€ç±³ç´™ã€Œãƒ‡ã‚¤ãƒªãƒ¼ãƒ»ãƒ‹ãƒ¥ãƒ¼ã‚¹ã€ãŒå ±ã˜ãŸã€‚ ä¸–ç•Œä¸ã§çŒ›å¨ã‚’ãµã‚‹ã†æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã€‚å„å›½ã§æ§˜ã€…ãªæ‹¡å¤§é˜²æ¢ç–ãŒå–ã‚‰ã‚Œã‚‹ä¸ã€ã‚¹ã‚¦ã‚§ãƒ¼ãƒ‡ãƒ³ã§ã¯å¦æ ¡ã€ã‚¸ãƒ ã€ãƒ¬ã‚¹ãƒˆãƒ©ãƒ³ãªã©ãŒå–¶æ¥ã‚’ç¶šã‘ãªãŒã‚‰ã‚‚å›½æ°‘ã¸ã€Œã‚½ãƒ¼ã‚·ãƒ£ãƒ«ãƒ»ãƒ‡ã‚£ã‚¹ã‚¿ãƒ³ã‚¹ã€ã‚’æ„è˜ã™ã‚‹ã‚ˆã†ã«å‘¼ã³ã‹ã‘ã€å¯¾å¿œã—ã¦ããŸã€‚ãã‚“ãªä¸ã§ã‚¹ã‚¦ã‚§ãƒ¼ãƒ‡ãƒ³å…¬è¡†è¡›ç”Ÿå±€ã®ç–«å¦è€…ã‚¢ãƒ³ãƒ€ãƒ¼ã‚¹ãƒ»ãƒ†ã‚°ãƒãƒ«æ°ãŒã€Œé›†å›£å…ç–«ã‚’æŒã¡å§‹ã‚ãŸã€ã¨ã®è€ƒãˆã‚’ç¤ºã—ãŸã“ã¨ã‚’19æ—¥(æ—¥æœ¬æ™‚é–“20æ—¥)ã€ç±³ç´™ã€Œãƒ‡ã‚¤ãƒªãƒ¼ãƒ»ãƒ‹ãƒ¥ãƒ¼ã‚¹ã€ãŒå ±ã˜ãŸã€‚ ã€Œã‚¹ã‚¦ã‚§ãƒ¼ãƒ‡ãƒ³ãŒé›†å›£å…ç–«ãŒè¿‘
belgianbeer 2020/04/22
å…ç–«

COVID-19

æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹
ãƒªãƒ³ã‚¯
1